Dexamethasone suppression test response in major depression: stability across hospitalizations

Area of Science:

• Neuroendocrinology
• Psychiatry

Background:

• The hypothalamic-pituitary-adrenal (HPA) axis is frequently studied in depression.
• Dexamethasone suppression tests (DSTs) are used to assess HPA axis activity.

Purpose of the Study:

• To evaluate the reliability of DST results in patients with depression across separate admissions.
• To explore the relationship between DST results and depression subtypes.

Main Methods:

• 43 patients with definite depression underwent DSTs on two separate admissions.
• DST results were analyzed for discordance and correlation between admissions.
• Depression subtypes (bipolar/unipolar, primary/secondary) were examined in relation to DST outcomes.

Main Results:

• DST results were discordant in 21% of patients across admissions, with higher discordance (40.9%) among nonsuppressors.
• A significant correlation was found between post-dexamethasone values from both admissions.
• Distinguishing depression subtypes by DST results was inconsistent across admissions but clearer when pooled.

Conclusions:

• Abnormal dexamethasone suppression occurs in a significant portion of depressed patients.
• The temporal overlap between abnormal DSTs and the depressive syndrome may be limited.
• Negative DST results in primary depression require careful interpretation considering potential temporal discordance.